Pharmamarketeer
overig

Allergan’s Avycaz becomes first FDA-approved gram-negative antibiotic in over 15 years

7 februari 2018
Pharmafile

Allergan has announced that the FDA has awarded approval to its fixed-dose combination antibacterial Avycaaz (ceftazidme and avibactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in adult patients.

Reageer

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)